 MALVERN, Pa., July 29, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. Ocugen or the Company NASDAQ: OCGN, a biotechnology company focused on discovering, developing, and commercializing novel cell and gene therapies and vaccines, today announced that it will host a conference call and simultaneuous webcast to discuss the Companys second quarter 2022 financial results and provide a business update at 8:30 a.m. ET on Friday, August 5, 2022. 